China Traditional Chinese Medicine Holdings Co. Limited (0570.HK)
HKD 2.31
(-0.86%)
HKD 2.31
(-0.86%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.14 Billion CNY | 8.36% |
| 2022 | 1.97 Billion CNY | -8.82% |
| 2021 | 2.16 Billion CNY | 21.81% |
| 2020 | 1.78 Billion CNY | 1809.35% |
| 2019 | 93.25 Million CNY | -40.86% |
| 2018 | 157.68 Million CNY | -74.7% |
| 2017 | 623.17 Million CNY | -64.64% |
| 2016 | 1.76 Billion CNY | 405.76% |
| 2015 | 348.5 Million CNY | -52.44% |
| 2014 | 732.79 Million CNY | -19.16% |
| 2013 | 906.48 Million CNY | 147.94% |
| 2012 | 365.6 Million CNY | 54.02% |
| 2011 | 237.37 Million CNY | 489.05% |
| 2010 | -61.01 Million CNY | 53.63% |
| 2009 | -131.58 Million CNY | -8.66% |
| 2008 | -121.09 Million CNY | -56.95% |
| 2007 | -77.15 Million CNY | 12.88% |
| 2006 | -88.56 Million CNY | -128.99% |
| 2005 | 305.5 Million CNY | -9.31% |
| 2004 | 336.85 Million CNY | 34.34% |
| 2003 | 250.74 Million CNY | -35.18% |
| 2002 | 386.81 Million CNY | -37.44% |
| 2001 | 618.34 Million CNY | -3.22% |
| 2000 | 638.89 Million CNY | -6.56% |
| 1999 | 683.75 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.76 Billion CNY | -17.82% |
| 2024 Q2 | 1.76 Billion CNY | 6.69% |
| 2023 Q3 | 2.12 Billion CNY | -36.35% |
| 2023 Q4 | 2.14 Billion CNY | 0.88% |
| 2023 FY | 2.14 Billion CNY | 8.36% |
| 2023 Q2 | 3.33 Billion CNY | -16.62% |
| 2023 Q1 | 4 Billion CNY | 102.42% |
| 2022 Q1 | 2.66 Billion CNY | 22.92% |
| 2022 Q3 | 1.96 Billion CNY | -19.09% |
| 2022 Q4 | 1.97 Billion CNY | 0.85% |
| 2022 FY | 1.97 Billion CNY | -8.82% |
| 2022 Q2 | 2.42 Billion CNY | -9.1% |
| 2021 Q4 | 2.16 Billion CNY | 0.7% |
| 2021 Q1 | 2.43 Billion CNY | 36.7% |
| 2021 Q3 | 2.15 Billion CNY | 11.55% |
| 2021 Q2 | 1.93 Billion CNY | -20.67% |
| 2021 FY | 2.16 Billion CNY | 21.81% |
| 2020 Q2 | 2.13 Billion CNY | 0.56% |
| 2020 Q4 | 1.78 Billion CNY | 0.79% |
| 2020 FY | 1.78 Billion CNY | 1809.35% |
| 2020 Q1 | 2.12 Billion CNY | 2176.78% |
| 2020 Q3 | 1.76 Billion CNY | -17.26% |
| 2019 Q2 | 2.94 Billion CNY | 28.73% |
| 2019 Q4 | 93.25 Million CNY | -40.43% |
| 2019 Q3 | 156.53 Million CNY | -94.69% |
| 2019 Q1 | 2.28 Billion CNY | 1351.04% |
| 2019 FY | 93.25 Million CNY | -40.86% |
| 2018 Q4 | 157.68 Million CNY | 172.93% |
| 2018 Q1 | 1.8 Billion CNY | 189.66% |
| 2018 FY | 157.68 Million CNY | -74.7% |
| 2018 Q2 | 2.16 Billion CNY | 19.79% |
| 2018 Q3 | -216.2 Million CNY | -110.0% |
| 2017 Q4 | 623.17 Million CNY | 70.33% |
| 2017 Q1 | 2.09 Billion CNY | 18.86% |
| 2017 Q3 | 365.87 Million CNY | -82.54% |
| 2017 FY | 623.17 Million CNY | -64.64% |
| 2017 Q2 | 2.09 Billion CNY | 0.0% |
| 2016 Q3 | 1.53 Billion CNY | 90.89% |
| 2016 Q2 | 804.97 Million CNY | 0.0% |
| 2016 Q1 | 804.97 Million CNY | 130.98% |
| 2016 Q4 | 1.76 Billion CNY | 14.71% |
| 2016 FY | 1.76 Billion CNY | 405.76% |
| 2015 Q2 | -4.86 Billion CNY | 0.0% |
| 2015 Q4 | 348.5 Million CNY | 0.0% |
| 2015 FY | 348.5 Million CNY | -52.44% |
| 2015 Q3 | 348.5 Million CNY | 107.17% |
| 2015 Q1 | -4.86 Billion CNY | -763.29% |
| 2014 Q2 | 808.39 Million CNY | 0.0% |
| 2014 FY | 732.79 Million CNY | -19.16% |
| 2014 Q4 | 732.79 Million CNY | 0.0% |
| 2014 Q1 | 808.39 Million CNY | -10.82% |
| 2014 Q3 | 732.79 Million CNY | -9.35% |
| 2013 Q3 | 906.48 Million CNY | 457.26% |
| 2013 FY | 906.48 Million CNY | 147.94% |
| 2013 Q4 | 906.48 Million CNY | 0.0% |
| 2013 Q2 | -253.72 Million CNY | 0.75% |
| 2013 Q1 | -255.63 Million CNY | -169.92% |
| 2012 Q3 | -46.25 Million CNY | -117.49% |
| 2012 FY | 365.6 Million CNY | 54.02% |
| 2012 Q2 | 264.41 Million CNY | 0.0% |
| 2012 Q4 | 365.6 Million CNY | 890.35% |
| 2011 Q4 | 237.37 Million CNY | 0.0% |
| 2011 Q2 | 119.4 Million CNY | 0.0% |
| 2011 FY | 237.37 Million CNY | 489.05% |
| 2010 Q4 | -61.01 Million CNY | 0.0% |
| 2010 FY | -61.01 Million CNY | 53.63% |
| 2010 Q2 | -121.89 Million CNY | 0.0% |
| 2009 Q4 | -131.58 Million CNY | 0.0% |
| 2009 FY | -131.58 Million CNY | -8.66% |
| 2009 Q2 | -42.44 Million CNY | 0.0% |
| 2008 FY | -121.09 Million CNY | -56.95% |
| 2008 Q4 | -121.09 Million CNY | 0.0% |
| 2007 FY | -77.15 Million CNY | 12.88% |
| 2006 FY | -88.56 Million CNY | -128.99% |
| 2005 FY | 305.5 Million CNY | -9.31% |
| 2004 FY | 336.85 Million CNY | 34.34% |
| 2003 FY | 250.74 Million CNY | -35.18% |
| 2002 FY | 386.81 Million CNY | -37.44% |
| 2001 FY | 618.34 Million CNY | -3.22% |
| 2000 FY | 638.89 Million CNY | -6.56% |
| 1999 FY | 683.75 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | -258.7 Million HKD | 928.292% |
| Grand Pharmaceutical Group Limited | 2.03 Billion HKD | -5.461% |
| Extrawell Pharmaceutical Holdings Limited | 5.94 Million HKD | -35950.067% |
| Wai Yuen Tong Medicine Holdings Limited | 301.53 Million HKD | -610.634% |
| Qianhai Health Holdings Limited | -19.03 Million HKD | 11355.468% |
| Lee's Pharmaceutical Holdings Limited | 30.94 Million HKD | -6823.924% |
| Essex Bio-Technology Limited | -219.22 Million HKD | 1077.433% |
| Tongfang Kontafarma Holdings Limited | 256.16 Million HKD | -736.502% |
| PuraPharm Corporation Limited | 377.54 Million HKD | -467.56% |
| SSY Group Limited | 1.71 Billion HKD | -25.053% |
| JBM (Healthcare) Limited | -7.39 Million HKD | 29060.887% |
| Jacobson Pharma Corporation Limited | 337.44 Million HKD | -535.018% |
| China Resources Pharmaceutical Group Limited | 50.97 Billion HKD | 95.797% |